An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
Thomas Jefferson University
Thomas Jefferson University
Takeda
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
Taiho Oncology, Inc.
Bolt Biotherapeutics, Inc.
Sanofi
Washington University School of Medicine
University of Virginia
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
NRG Oncology
NextCure, Inc.
Elevation Oncology
Turnstone Biologics, Corp.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
National Cancer Institute (NCI)
NantCell, Inc.
Washington University School of Medicine
Pfizer
Ikena Oncology
Ikena Oncology
Cambridge University Hospitals NHS Foundation Trust
CytomX Therapeutics
Atreca, Inc.
Fusion Pharmaceuticals Inc.
Biocept, Inc.
Pfizer
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche
West Virginia University
University of Maryland, Baltimore
Ipsen
Silverback Therapeutics
Stanford University
Centre Hospitalier Universitaire Vaudois
MacroGenics
Novartis
National Institutes of Health Clinical Center (CC)
Advanced Accelerator Applications
Seagen Inc.
AIDS Malignancy Consortium
National Institutes of Health Clinical Center (CC)
Lumos Pharma
Pfizer
Tetra Bio-Pharma
InSightec